Eupraxia Pharmaceuticals Inc.

12 records totalling $3,508,528.00 CAD, from official Government of Canada open data.

Embed this chart

By department

National Research Council Canada $3,508,528 12 records

Records

Eupraxia Pharmaceuticals Inc. $924,000.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
FY 2018-2019
Canada

Development of a sustained-release, antibiotic drug product that is more effective than the current treatments for the prophylactic prevention of post-surgical infections will be advanced through prec...

Eupraxia Pharmaceuticals Inc. $700,000.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
FY 2021-2022
Canada

This project will determine the safety, metabolism and clearance of the novel coating, in particular the polymer component, of the firm's extended-release technology platform through in vivo studies t...

Eupraxia Pharmaceuticals Inc. $255,400.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
FY 2018-2019
Canada

An antibiotic film product will be developed that exhibits sustained-release delivery of high local concentrations of antibiotic at surgical sites for extended duration with limited systemic exposures...

Eupraxia Pharmaceuticals Inc. $201,964.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Innovation Assistance Program
FY 2020-2021
Canada

The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.

Eupraxia Pharmaceuticals Inc. $142,296.00
National Research Council Canada | Conseil national de recherches Canada
Innovation Assistance Program
FY 2020-2021
Canada

The funding provided by the IAP program is intended to assist innovative small and medium-sized enterprises in the start-up phase that cannot access existing commercial support related to COVID-19.

Eupraxia Pharmaceuticals Inc. $75,868.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Innovation Assistance Program
FY 2020-2021
Canada

The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.

Eupraxia Pharmaceuticals Inc. $36,000.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Youth Employment Program
FY 2021-2022
Canada

The graduate will be involved in the scientific design, execution and management of recrystallization and analytical test development and will gain experience managing development projects.